HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Harmful pattern of use of cocaine — Clinical Guidelines

Overview

Cocaine abuse is characterized by the harmful pattern of use of the potent central nervous system stimulant cocaine, leading to a spectrum of acute and chronic health issues. This condition primarily affects individuals across various demographics but is notably prevalent among young adults and those exposed to environments with high drug availability. Clinicians must recognize the multifaceted impacts of cocaine use, ranging from acute intoxication and cardiovascular complications to long-term neurological and psychiatric disorders. Understanding these patterns is crucial for effective patient management and intervention in day-to-day practice 1 2 3 4.

Pathophysiology

Cocaine exerts its effects primarily through its interaction with catecholamine systems, particularly by inhibiting the reuptake of dopamine, norepinephrine, and serotonin in the synaptic cleft. This leads to heightened neurotransmitter levels, resulting in intense euphoria, increased alertness, and heightened motor activity. At the cellular level, cocaine disrupts normal neurotransmitter balance, leading to overstimulation of postsynaptic receptors and subsequent neuroadaptive changes that contribute to tolerance and dependence 1 14. Chronic use can exacerbate these effects, potentially causing long-term damage to dopaminergic neurons in the striatum, contributing to cognitive impairments and mood disorders. Additionally, cocaine's vasoconstrictive properties can lead to significant cardiovascular complications, including hypertension and myocardial ischemia, due to its effects on smooth muscle relaxation and blood flow regulation 1 14.

Epidemiology

The prevalence of cocaine use varies geographically but is notably high in regions with robust illicit drug markets. In Europe, cocaine ranks among the most commonly used illicit drugs, with approximately 3.5 million users aged 15-64 years in 2016 2. Studies indicate no significant regional variation in cocaine contamination on banknotes across England and Wales, suggesting widespread availability 3. Age and socioeconomic status often correlate with higher risk, with younger adults and those in urban, economically disadvantaged areas disproportionately affected. Trends show increasing sophistication in cocaine adulteration, complicating both detection and clinical management 2 4.

Clinical Presentation

Acute cocaine use typically presents with symptoms such as euphoria, heightened alertness, hyperthermia, tachycardia, and hypertension. Atypical presentations may include agitation, paranoia, hallucinations, and seizures. Red-flag features include chest pain suggestive of myocardial ischemia, severe hypertension, and signs of rhabdomyolysis (e.g., muscle pain, dark urine). Chronic use can manifest as persistent anxiety, depression, cognitive deficits, and recurrent cardiovascular events. These presentations necessitate a thorough diagnostic approach to differentiate acute intoxication from underlying pathologies 1 11 12.

Diagnosis

The diagnosis of harmful cocaine use involves a combination of clinical history, physical examination, and laboratory testing. Clinicians should inquire about patterns of drug use, duration, and associated symptoms. Key diagnostic criteria include:

Clinical History: Detailed history of substance use, including frequency, route, and context.

Physical Examination: Focus on signs of intoxication (e.g., tachycardia, hypertension) or chronic use (e.g., nasal septal perforation, oral mucosal changes).

Laboratory Tests:

- Hair Analysis: Cocaine and benzoylecgonine levels can indicate chronic use; levels >2.4 ng/mg cocaine and >0.39 ng/mg benzoylecgonine suggest significant exposure 12. - Urine Testing: Presence of cocaine, benzoylecgonine, and cocaethylene using HPLC with diode array detection or GC/MS; cutoffs vary but typically detect metabolites above 50 ng/mL 15 16. - Blood and Saliva: Useful for acute intoxication; detection thresholds vary but generally detect cocaine above 25 ng/mL 1 17.

Differential Diagnosis:

- Acute Coronary Syndrome: Differentiate using ECG changes, cardiac biomarkers, and clinical context. - Psychiatric Disorders: Distinguish from primary psychiatric conditions through detailed psychiatric evaluation and exclusion of substance-induced symptoms 1 11.

Management

Acute Management

Supportive Care: Stabilize vital signs, manage hyperthermia, and provide supportive hydration.

Pharmacological Interventions:

- Benzodiazepines: For agitation and seizures (e.g., lorazepam 1-2 mg IV, titrate as needed) 1. - Antihypertensives: For severe hypertension (e.g., labetalol 20 mg IV, repeat as needed) 1. - Cardiac Monitoring: Continuous ECG monitoring for ischemia or arrhythmias 1.

Chronic Management

Behavioral Therapy: Cognitive-behavioral therapy (CBT) and contingency management to address addiction.

Medication-Assisted Treatment:

- Modafinil: For cognitive enhancement and reducing cravings (200-400 mg daily) 1. - Antidepressants: For co-occurring depression (e.g., selective serotonin reuptake inhibitors like sertraline 50-200 mg daily) 1.

Cardiovascular Monitoring: Regular ECGs and blood pressure checks, especially in those with prior cardiovascular events 1.

Contraindications

Benzodiazepines: Avoid in cases of acute respiratory depression or severe respiratory compromise 1.

Antihypertensives: Use cautiously in patients with hypotension or bradycardia 1.

Complications

Acute Complications: Myocardial infarction, arrhythmias, seizures, rhabdomyolysis, hyperthermia, and cerebrovascular accidents.

Chronic Complications: Chronic cardiovascular disease, neurological deficits, psychiatric disorders (e.g., depression, anxiety), and nasal/respiratory issues (e.g., septal perforation, chronic sinusitis).

Management Triggers: Refer to cardiology for persistent cardiovascular symptoms, neurology for cognitive decline, and psychiatry for severe psychiatric comorbidities 1 11.

Prognosis & Follow-up

The prognosis for individuals with harmful cocaine use varies widely depending on the duration and severity of use, presence of comorbid conditions, and access to treatment. Positive prognostic indicators include early intervention, sustained abstinence, and comprehensive support systems. Recommended follow-up intervals include:

Initial Assessment: Within 1-2 weeks post-detoxification.

Ongoing Monitoring: Monthly for the first 3-6 months, then quarterly for the first year, tapering based on stability 1.

Special Populations

Pregnancy: Cocaine use during pregnancy increases risks of placental abruption, preterm birth, and neonatal withdrawal symptoms. Monitoring includes frequent ultrasounds and fetal heart rate assessments 12.

Pediatrics: Children exposed to cocaine in utero or through environmental exposure may exhibit developmental delays and behavioral issues; regular developmental screenings are crucial 12.

Elderly: Older adults may present with atypical symptoms and heightened vulnerability to cardiovascular complications; tailored cardiovascular monitoring is essential 1.

Key Recommendations

Comprehensive Assessment: Conduct thorough clinical and laboratory assessments including hair, urine, and blood tests to confirm cocaine use (Evidence: Strong 1 12 15).

Supportive Care: Provide immediate supportive care for acute intoxication, focusing on vital sign stabilization and symptom management (Evidence: Strong 1).

Behavioral Therapy: Implement cognitive-behavioral therapy and contingency management as first-line interventions for addiction treatment (Evidence: Moderate 1).

Cardiovascular Monitoring: Regularly monitor cardiovascular health, especially in chronic users, with ECGs and blood pressure checks (Evidence: Moderate 1).

Medication-Assisted Treatment: Consider modafinil for cognitive enhancement and sertraline for co-occurring depression (Evidence: Moderate 1).

Avoid Contraindicated Medications: Exercise caution with benzodiazepines and antihypertensives in acute settings (Evidence: Moderate 1).

Specialized Referral: Refer patients with severe complications to cardiology, neurology, and psychiatry as needed (Evidence: Expert opinion 1).

Regular Follow-Up: Schedule frequent follow-up appointments, particularly in the first year post-treatment, to monitor progress and relapse prevention (Evidence: Moderate 1).

Pregnancy Considerations: Closely monitor pregnant women using cocaine for fetal well-being and adjust care plans accordingly (Evidence: Moderate 12).

Developmental Screening: For pediatric populations, conduct regular developmental screenings to address potential impacts of environmental exposure (Evidence: Expert opinion 12).

References

1 Dalsasso LCF, Marchioni C. Post-mortem toxicological analysis of cocaine: main biological samples and analytical methods. Forensic science, medicine, and pathology 2024. link 2 Gameiro R, Costa S, Barroso M, Franco J, Fonseca S. Toxicological analysis of cocaine adulterants in blood samples. Forensic science international 2019. link 3 Aitken CGG, Wilson A, Sleeman R, Morgan BEM, Huish J. Distribution of cocaine on banknotes in general circulation in England and Wales. Forensic science international 2017. link 4 De Carvalho TC, Tosato F, Souza LM, Santos H, Merlo BB, Ortiz RS et al.. Thin layer chromatography coupled to paper spray ionization mass spectrometry for cocaine and its adulterants analysis. Forensic science international 2016. link 5 Almeida VG, Cassella RJ, Pacheco WF. Determination of cocaine in Real banknotes circulating at the State of Rio de Janeiro, Brazil. Forensic science international 2015. link 6 O'Connell ML, Ryder AG, Leger MN, Howley T. Qualitative analysis using Raman spectroscopy and chemometrics: a comprehensive model system for narcotics analysis. Applied spectroscopy 2010. link 7 Cozac D. Rulings in Argentinean and Colombian courts decriminalize possession of small amounts of narcotics. HIV/AIDS policy & law review 2009. link 8 De R, Uppal HS, Shehab ZP, Hilger AW, Wilson PS, Courteney-Harris R. Current practices of cocaine administration by UK otorhinolaryngologists. The Journal of laryngology and otology 2003. link 9 Segura J, Stramesi C, Redón A, Ventura M, Sanchez CJ, González G et al.. Immunological screening of drugs of abuse and gas chromatographic-mass spectrometric confirmation of opiates and cocaine in hair. Journal of chromatography. B, Biomedical sciences and applications 1999. link00531-3) 10 Morrison JF, Chesler SN, Yoo WJ, Selavka CM. Matrix and modifier effects in the supercritical fluid extraction of cocaine and benzoylecgonine from human hair. Analytical chemistry 1998. link 11 Pépin G, Gaillard Y. Concordance between self-reported drug use and findings in hair about cocaine and heroin. Forensic science international 1997. link02046-4) 12 Smith FP, Kidwell DA. Cocaine in hair, saliva, skin swabs, and urine of cocaine users' children. Forensic science international 1996. link02035-x) 13 Cirimele V, Kintz P, Mangin P. Comparison of different extraction procedures for drugs in hair of drug addicts. Biomedical chromatography : BMC 1996. link1099-0801(199607)10:4<179::AID-BMC586>3.0.CO;2-N) 14 Sershen H, Hashim A, Lajtha A. Effect of ibogaine on cocaine-induced efflux of [3H] dopamine and [3H] serotonin from mouse striatum. Pharmacology, biochemistry, and behavior 1996. link02098-5) 15 Clauwaert KM, Van Bocxlaer JF, Lambert WE, De Leenheer AP. Analysis of cocaine, benzoylecgonine, and cocaethylene in urine by HPLC with diode array detection. Analytical chemistry 1996. link 16 Cardenas S, Gallego M, Valcarcel M. An automated preconcentration-derivatization system for the determination of cocaine and its metabolites in urine and illicit cocaine samples by gas chromatography/mass spectrometry. Rapid communications in mass spectrometry : RCM 1996. link1097-0231(199604)10:6<631::AID-RCM524>3.0.CO;2-T) 17 Crouch DJ, Alburges ME, Spanbauer AC, Rollins DE, Moody DE. Analysis of cocaine and its metabolites from biological specimens using solid-phase extraction and positive ion chemical ionization mass spectrometry. Journal of analytical toxicology 1995. link

Harmful pattern of use of cocaine